Home
>
National Drug Code (NDC)
>
Vecuronium Bromide
Vecuronium Bromide - 0703-2925-03 - (Vecuronium Bromide)
Drug Information of Vecuronium Bromide
| Product NDC: | 0703-2925 |
| Proprietary Name: | Vecuronium Bromide |
| Non Proprietary Name: | Vecuronium Bromide |
| Active Ingredient(s): | 20 mg/20mL & nbsp; Vecuronium Bromide |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Vecuronium Bromide
| Product NDC: | 0703-2925 |
| Labeler Name: | Teva Parenteral Medicines, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074688 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20021114 |
Package Information of Vecuronium Bromide
| Package NDC: | 0703-2925-03 |
| Package Description: | 10 VIAL, SINGLE-USE in 1 TRAY (0703-2925-03) > 20 mL in 1 VIAL, SINGLE-USE (0703-2925-01) |
NDC Information of Vecuronium Bromide
| NDC Code | 0703-2925-03 |
| Proprietary Name | Vecuronium Bromide |
| Package Description | 10 VIAL, SINGLE-USE in 1 TRAY (0703-2925-03) > 20 mL in 1 VIAL, SINGLE-USE (0703-2925-01) |
| Product NDC | 0703-2925 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Vecuronium Bromide |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20021114 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Parenteral Medicines, Inc. |
| Substance Name | VECURONIUM BROMIDE |
| Strength Number | 20 |
| Strength Unit | mg/20mL |
| Pharmaceutical Classes | Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] |
